Not applicableUnknownNCT03659110
What this trial is testing
Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice
Who this might be right for
Cervical Cancer
Beijing Chaoyang District Centre for Disease Control and Prevention 1,000